Results 51 to 60 of about 430,860 (160)

PPAR-γ in the Cardiovascular System

open access: yes, 2008
Peroxisome proliferator-activated receptor-γ (PPAR-γ), an essential transcriptional mediator of adipogenesis, lipid metabolism, insulin sensitivity, and glucose homeostasis, is increasingly recognized as a key player in inflammatory cells and in ...
Christine Y. Ivashchenko   +3 more
core   +1 more source

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease

open access: yesMolecules, 2020
The cytokine storm is an abnormal production of inflammatory cytokines, due to the over-activation of the innate immune response. This mechanism has been recognized as a critical mediator of influenza-induced lung disease, and it could be pivotal for ...
Carmen Ciavarella   +3 more
doaj   +1 more source

Myeloid PPAR-γ deficiency leads to unresolved persistent fibrosis.

open access: yes, 2019
(A) WT (Ppargfl/fl) or PPAR-γ cKO (PpargΔLyz2) mice were infected with influenza virus. H&E staining of lung sections from WT or PPAR-γ cKO mice at day 60 p.i.
Eva M. Carmona (7465466)   +13 more
core   +1 more source

Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition [PDF]

open access: yes, 2016
Transient receptor potential channel C6 (TRPC6) gain-of-function mutations and increased TRPC6 expression in podocytes induce glomerular injury and proteinuria.
van der Vlag, Johan   +26 more
core   +2 more sources

PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty

open access: yesJournal of Lipid Research, 2012
Peroxisome proliferator-activated receptor γ (PPAR-γ) is a key regulator of fatty acid metabolism, promoting its storage in adipose tissue and reducing circulating concentrations of free fatty acids. Activation of PPAR-γ has favorable effects on measures
Janice V. Huang   +2 more
doaj   +1 more source

Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts

open access: yesBMC Gastroenterology, 2017
Background Intestinal fibrosis is a serious complication of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. There is no specific treatment for intestinal fibrosis.
Jun Bon Koo   +12 more
doaj   +1 more source

PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND:It has been reported that peroxisome proliferator-activated receptor (PPAR)-γ and their synthetic ligands have direct effects on pancreatic β-cells.
Hyo-Sup Kim   +6 more
doaj   +1 more source

MHY908 functioned as a PPAR α/γ dual agonist.

open access: yes, 2013
(A) The chemical structure of MHY908. (B) ChIP assay for PPARs binding to PPRE of the PPAR α or γ promoter. The extracted genomic DNA was subjected to immunoprecipitation using an antibody against PPAR α and PPAR γ or IgG as a negative control ...
Dae Hyun Kim (267092)   +9 more
core   +1 more source

PPAR-γ and aging: one link through klotho? [PDF]

open access: yes, 2008
PPAR-γ, a transcription factor involved in adipogenesis, glucose homeostasis, bone turnover, and inflammation, has now been shown to increase klotho expression.
Zheng, Feng, Zhang, Ruihua
core   +1 more source

Three-in-One Agonists for PPAR-α, PPAR-γ, and PPAR-δ from Traditional Chinese Medicine

open access: yes, 2012
[[abstract]]Nowadays, the occurrence of metabolic syndrome, which is characterized by obesity and clinical disorders, has been increasing rapidly over the world.
陳語謙;Chen, Calvin Yu-Chian
core  

Home - About - Disclaimer - Privacy